Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Grande Portage Resources (V.GPG) Initiates Sensor-Based Ore Sorting Testwork (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Heart Test Laboratories Equity Warrant Exp 15th June 2027 HSCSW

HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its... see more

Recent & Breaking News (NDAQ:HSCSW)

HeartSciences Announces Completion of Patient Enrollment for FDA Pivotal Study of MyoVista wavECG

GlobeNewswire May 9, 2023

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

GlobeNewswire May 8, 2023

HeartSciences to Participate in The Benchmark Company's Virtual Individual Investor Healthcare Conference

GlobeNewswire May 2, 2023

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

GlobeNewswire April 17, 2023

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

GlobeNewswire March 16, 2023

HeartSciences CEO Invited as Featured Guest on The Big Biz Show, February 7 at 11:45 a.m. Pacific Time

GlobeNewswire February 7, 2023

HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease

GlobeNewswire February 6, 2023

HeartSciences Announces Further Internationalization of its Patent Portfolio

GlobeNewswire February 3, 2023

Correction: HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th

GlobeNewswire January 23, 2023

HeartSciences CEO to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on January 25th

GlobeNewswire January 20, 2023

HeartSciences Appoints David R. Wells to its Board of Directors, an Experienced Capital Markets and Finance Executive

GlobeNewswire January 4, 2023

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results

GlobeNewswire December 16, 2022

HeartSciences and Rutgers University Announce Multi-Year Collaboration to Develop AI-based ECG Algorithms

GlobeNewswire December 1, 2022

HeartSciences to Present at the 2022 RHK Disruptive Growth Conference on December 5, 2022

GlobeNewswire November 28, 2022

HeartSciences to Participate at the Benchmark Discovery One-on-One Investor Conference on December 1, 2022

GlobeNewswire November 21, 2022

HeartSciences' MyoVista® Technology Used to Develop AI-ECG Algorithm to Identify Patients at High-Risk of Major Adverse Cardiovascular Events

GlobeNewswire November 10, 2022

HeartSciences Granted European Patent for Proprietary Electrode and Cable Connections for Use with its AI-Based MyoVista® ECG

GlobeNewswire October 25, 2022

HeartSciences Named as a Top 10 MedTech Startup 2022 by MedTech Outlook Magazine

GlobeNewswire October 20, 2022

HeartSciences Announces Major Milestone with the Issuance of CPT® Codes by the American Medical Association for ECG AI Analysis of Cardiac Dysfunction

GlobeNewswire October 19, 2022

HeartSciences to Present at MicroCap Rodeo's Windy City Roundup Conference on October 12th

Accesswire October 6, 2022